| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $103.88M | - | |
| Dir | 1.55M | $82.12M | - | |
| Dir | 1.19M | $62.87M | - | |
| CFO | 1.12M | $59.07M | - | |
| VP | 594.7K | $31.44M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2019 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sale+OE | 3,000 | $23.85 | $71,540.00 | -1.5% | |
| Jan 9, 2019 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sale+OE | 9,120 | $22.18 | $202,280.00 | -2.3% | |
| Jan 8, 2019 | Garber Alan M50 | Director | Sale+OE | 11,250 | $23.00 | $258,750.00 | -15.5% | |
| Jan 4, 2019 | Morrissey Michael | President And CEO | Sale+OE | 40,000 | $20.11 | $804,253.62 | -12.9% | |
| Jan 3, 2019 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sale+OE | 8,000 | $19.95 | $159,600.00 | -7.6% | |
| Jan 3, 2019 | Scangos George A77 | Director | Sell | 40,000 | $19.64 | $785,634.56 | -1.4% | |
| Dec 3, 2018 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 13,499 | $21.02 | $283,748.98 | -4.1% | |
| Dec 3, 2018 | Scangos George A77 | Director | Sell | 55,000 | $20.84 | $1,146,400.00 | -1.2% | |
| Nov 30, 2018 | Senner Christopher J. | EVP And CFO | Sell | 8,791 | $19.70 | $173,182.70 | -5.6% | |
| Nov 30, 2018 | Hessekiel Jeffrey54 | EVP And General Counsel | Sell | 14,818 | $19.25 | $285,290.37 | -2.1% |